| Product Code: ETC7539867 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market - Industry Life Cycle |
3.4 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market - Porter's Five Forces |
3.5 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume Share, By ACE Inhibitors, 2021 & 2031F |
3.7 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic kidney disease in India |
4.2.2 Growing awareness about the importance of early detection and treatment of CKD-MBD |
4.2.3 Technological advancements in the diagnosis and treatment of CKD-MBD |
4.3 Market Restraints |
4.3.1 High treatment costs associated with CKD-MBD management |
4.3.2 Limited access to specialized healthcare services in certain regions of India |
5 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Trends |
6 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By Types |
6.1 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Medications And Supplements, 2021- 2031F |
6.1.4 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Dialysis, 2021- 2031F |
6.1.5 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Surgery, 2021- 2031F |
6.1.6 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Diet, 2021- 2031F |
6.1.7 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.1.8 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.2 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By ACE Inhibitors |
6.2.1 Overview and Analysis |
6.2.2 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By B-blockers, 2021- 2031F |
6.2.3 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Calcium Channel Blockers, 2021- 2031F |
6.2.4 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Loop Diuretics, 2021- 2031F |
6.2.5 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Erythropoiesis-Stimulating Agents (ESAs), 2021- 2031F |
6.2.6 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Phosphate Binders, 2021- 2031F |
6.2.7 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.3.4 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.3 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Ambulatory Surgical Centres, 2021- 2031F |
6.4.5 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.5 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.5.3 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.4 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.5 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.6 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Import-Export Trade Statistics |
7.1 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Export to Major Countries |
7.2 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Imports from Major Countries |
8 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Key Performance Indicators |
8.1 Number of CKD-MBD screening programs implemented nationwide |
8.2 Adoption rate of new treatment modalities for CKD-MBD |
8.3 Percentage increase in healthcare expenditure allocated towards CKD-MBD management |
8.4 Average waiting time for patients seeking treatment for CKD-MBD |
8.5 Rate of patient adherence to prescribed treatment regimens |
9 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market - Opportunity Assessment |
9.1 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Opportunity Assessment, By ACE Inhibitors, 2021 & 2031F |
9.3 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market - Competitive Landscape |
10.1 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenue Share, By Companies, 2024 |
10.2 India Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here